AMELUZ (Biofrontera Inc.)


Welcome to the PulseAid listing for the AMELUZ drug offered from Biofrontera Inc.. This Porphyrin Precursor [EPC],Porphyrinogens [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Biofrontera Inc.
NON-PROPRIETARY NAME: aminolevulinic acid hydrochloride
SUBSTANCE NAME: AMINOLEVULINIC ACID HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Porphyrin Precursor [EPC],Porphyrinogens [Chemical/Ingredient]
ROUTE: TOPICAL
DOSAGE FORM: GEL
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-08-26
END MARKETING DATE: 0000-00-00


AMELUZ HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAMELUZ from Biofrontera Inc.
LABELER NAME: Biofrontera Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/g)
START MARKETING DATE: 2016-08-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70621-101_06c09242-ddf3-4ea2-b2e2-e7a6ca753df3
PRODUCT NDC: 70621-101
APPLICATION NUMBER: NDA208081

Other AMINOLEVULINIC ACID HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Biofrontera Inc.AMELUZ